Neurosurgery, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA.
Neurosurgery, Gates Vascular Institute, Buffalo, New York, USA.
J Neurointerv Surg. 2022 Apr;14(4):366-370. doi: 10.1136/neurintsurg-2021-017613. Epub 2021 Jul 15.
The Woven EndoBridge (WEB) device is a barrel-shaped nitinol mesh deployed within the aneurysmal sac. The absence of metallic mesh in the aneurysm's parent vessel lumen obviates the need for potent antiplatelet therapy, making this device appealing for acutely ruptured aneurysms not amenable to clipping or coiling. To assess the literature regarding WEB treatment of these aneurysms, we performed a comprehensive systematic search of PubMed, MEDLINE, and EMBASE databases following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Keywords were combined with Boolean operators to increase search sensitivity and specificity ('woven endobridge device' AND 'ruptured'). Nine studies comprising 377 acutely ruptured aneurysms were included. Overall, 82.7% were wide-necked, 85.9% were located in the anterior circulation, and 26.9% of patients presented with poor subarachnoid hemorrhage grade. Intraprocedure and postprocedure complications occurred in 8.4% (95% CI 3.6% to 13.3%) and 1% (95% CI 0% to 2%), respectively. The post-treatment rebleeding rate was 0%. Rates of adequate occlusion (complete occlusion to neck remnant) and retreatment at last follow-up were 84.8% (95% CI 73% to 96.6%) and 4.5% (95% CI 2.2% to 6.8%), respectively. The favorable outcome rate (modified Rankin Scale score 0-2) was 62.2% (95% CI 53% to 71.4%); mortality was 13.6% (95% CI 9.7% to 17.6%). WEB treatment of acutely ruptured aneurysms results in high adequate occlusion rates, low perioperative complication rates, no rebleeding, and low recurrence requiring retreatment. This device is promising for acutely ruptured aneurysms not amenable to clipping or coiling, considering the lower need for antiplatelet regimens during the procedure or follow-up.
Woven EndoBridge(WEB)装置是一种桶形形状的镍钛诺网,部署在动脉瘤囊中。由于动脉瘤的母体血管腔中没有金属网,因此无需进行强效抗血小板治疗,这使得该装置对于无法夹闭或线圈栓塞的急性破裂动脉瘤具有吸引力。为了评估 WEB 治疗这些动脉瘤的文献,我们根据系统评价和荟萃分析的首选报告项目(PRISMA)指南,对 PubMed、MEDLINE 和 EMBASE 数据库进行了全面的系统搜索。使用布尔运算符组合关键词以提高搜索的敏感性和特异性(“woven endobridge device”和“ruptured”)。纳入了 9 项研究,共 377 例急性破裂动脉瘤。总体而言,82.7%为宽颈动脉瘤,85.9%位于前循环,26.9%的患者蛛网膜下腔出血分级较差。术中并发症和术后并发症的发生率分别为 8.4%(95%CI 3.6%至 13.3%)和 1%(95%CI 0%至 2%)。治疗后再出血率为 0%。治疗后闭塞率(完全闭塞至残余瘤颈)和末次随访时再治疗率分别为 84.8%(95%CI 73%至 96.6%)和 4.5%(95%CI 2.2%至 6.8%)。良好结局率(改良Rankin 量表评分 0-2)为 62.2%(95%CI 53%至 71.4%);死亡率为 13.6%(95%CI 9.7%至 17.6%)。WEB 治疗急性破裂动脉瘤可获得较高的闭塞率、较低的围手术期并发症率、无再出血、以及较低的需要再次治疗的复发率。考虑到在手术过程中或随访期间需要较低的抗血小板治疗方案,该装置对于无法夹闭或线圈栓塞的急性破裂动脉瘤具有广阔的应用前景。